CASC3 and plasma cell myeloma: Indeed, MM patients who failed to respond to BTZ (n = 3) showed higher colocalization of CXCR4 with myeloma PCs compared with patients who responded (n = 3; p < 0.05 versus responders; Fig. 6C).